Результаты исследований: Научные публикации в периодических изданиях › обзорная статья › Рецензирование
Abnormal mTOR Activity in Pediatric Autoimmune Neuropsychiatric and MIA-Associated Autism Spectrum Disorders. / Trifonova, Ekaterina A.; Mustafin, Zakhar S.; Lashin, Sergey A. и др.
в: International Journal of Molecular Sciences, Том 23, № 2, 967, 16.01.2022.Результаты исследований: Научные публикации в периодических изданиях › обзорная статья › Рецензирование
}
TY - JOUR
T1 - Abnormal mTOR Activity in Pediatric Autoimmune Neuropsychiatric and MIA-Associated Autism Spectrum Disorders
AU - Trifonova, Ekaterina A.
AU - Mustafin, Zakhar S.
AU - Lashin, Sergey A.
AU - Kochetov, Alex V.
N1 - Funding Information: Funding: This research was supported by the Russian State Budgetary Projects FWNR-2022-0006 and FWNR-2022-0020. Publisher Copyright: © 2022 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2022/1/16
Y1 - 2022/1/16
N2 - Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by the early onset of communication and behavioral problems. ASD is highly heritable; however, environmental factors also play a considerable role in this disorder. A significant part of both syndromic and idiopathic autism cases could be attributed to disorders caused by mammalian target of rapamycin (mTOR)-dependent translation deregulation. This narrative review analyzes both bioinformatic and experimental evidence that connects mTOR signaling to the maternal autoantibody-related (MAR) autism spectrum and autoimmune neuropsychiatric disorders simultaneously. In addition, we reconstruct a network presenting the interactions between the mTOR signaling and eight MAR ASD genes coding for ASD-specific maternal autoantibody target proteins. The research discussed in this review demonstrates novel perspectives and validates the need for a subtyping of ASD on the grounds of pathogenic mechanisms. The utter necessity of designing ELISA-based test panels to identify all antibodies related to autism-like behavior is also considered.
AB - Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by the early onset of communication and behavioral problems. ASD is highly heritable; however, environmental factors also play a considerable role in this disorder. A significant part of both syndromic and idiopathic autism cases could be attributed to disorders caused by mammalian target of rapamycin (mTOR)-dependent translation deregulation. This narrative review analyzes both bioinformatic and experimental evidence that connects mTOR signaling to the maternal autoantibody-related (MAR) autism spectrum and autoimmune neuropsychiatric disorders simultaneously. In addition, we reconstruct a network presenting the interactions between the mTOR signaling and eight MAR ASD genes coding for ASD-specific maternal autoantibody target proteins. The research discussed in this review demonstrates novel perspectives and validates the need for a subtyping of ASD on the grounds of pathogenic mechanisms. The utter necessity of designing ELISA-based test panels to identify all antibodies related to autism-like behavior is also considered.
KW - Autism spectrum disorder (ASD)
KW - Autoimmune disorders (AIDs)
KW - Bioinformatics
KW - Genetics
KW - Maternal autoantibody-related (MAR) ASD
KW - Maternal immune activation (MIA)
KW - MTOR signaling pathway
KW - Pediatric autoimmune neuropsychiatric disorder associated with streptococcal infections (PANDAS)
UR - http://www.scopus.com/inward/record.url?scp=85122836985&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/348a36e2-03c9-3fd6-8096-e7fabbcc3989/
U2 - 10.3390/ijms23020967
DO - 10.3390/ijms23020967
M3 - Review article
C2 - 35055151
AN - SCOPUS:85122836985
VL - 23
JO - International Journal of Molecular Sciences
JF - International Journal of Molecular Sciences
SN - 1661-6596
IS - 2
M1 - 967
ER -
ID: 35263299